SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-010280
Filing Date
2013-08-08
Accepted
2013-08-08 16:10:40
Documents
14
Period of Report
2013-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdli20130808_8k.htm 8-K 27373
2 EXHIBIT 99.1 ex99-1.htm EX-99 203513
3 EXHIBIT 99.2 ex99-2.htm EX-99 5072
4 EXHIBIT 99.3 ex99-3.htm EX-99 584428
5 pdlbiologo.jpg GRAPHIC 2710
6 slide9.jpg GRAPHIC 43799
7 slide8.jpg GRAPHIC 75114
8 slide7.jpg GRAPHIC 81865
9 slide6.jpg GRAPHIC 80764
10 slide5.jpg GRAPHIC 90263
11 slide4.jpg GRAPHIC 126918
12 slide3.jpg GRAPHIC 104461
13 slide2.jpg GRAPHIC 159885
14 slide1.jpg GRAPHIC 63738
  Complete submission text file 0001437749-13-010280.txt   1965698
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 131022288
SIC: 2836 Biological Products, (No Diagnostic Substances)